Global Normal Saline for Parenteral Use Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Normal Saline for Parenteral Use Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.

This report studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection

According to our (Global Info Research) latest study, the global Normal Saline for Parenteral Use market size was valued at US$ 3338 million in 2023 and is forecast to a readjusted size of USD 4130 million by 2030 with a CAGR of 3.1% during review period.

At present, Baxter, Kelun Group, B. Braun, Fresenius Kabi and SSY Group are the top five manufacturers of gastrointestinal saline in the world, with a total market share of more than 45%.They are also the world"s largest companies by sales.

This report is a detailed and comprehensive analysis for global Normal Saline for Parenteral Use market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Normal Saline for Parenteral Use market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2019-2030

Global Normal Saline for Parenteral Use market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2019-2030

Global Normal Saline for Parenteral Use market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2019-2030

Global Normal Saline for Parenteral Use market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/K Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Normal Saline for Parenteral Use

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Normal Saline for Parenteral Use market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, Pfizer, B. Braun, ICU Medical, Fresenius Kabi, Otsuka, Kelun Group, CR Double-Cran, SSY Group, Cisen Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Normal Saline for Parenteral Use market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Flexible Bag
Plastic Bottles
Glass Bottles

Market segment by Application
Intramuscular Injection
Intravenous Injection
Others

Major players covered
Baxter
Pfizer
B. Braun
ICU Medical
Fresenius Kabi
Otsuka
Kelun Group
CR Double-Cran
SSY Group
Cisen Pharmaceutical
Denis Chem Lab Limited
Shree Krishnakeshav Laboratories
Pharmally International

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Normal Saline for Parenteral Use product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Normal Saline for Parenteral Use, with price, sales quantity, revenue, and global market share of Normal Saline for Parenteral Use from 2019 to 2024.

Chapter 3, the Normal Saline for Parenteral Use competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Normal Saline for Parenteral Use breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Normal Saline for Parenteral Use market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Normal Saline for Parenteral Use.

Chapter 14 and 15, to describe Normal Saline for Parenteral Use sales channel, distributors, customers, research findings and conclusion.